BIO-CAT Microbials Releases Safety Manuscript on New Proprietary Bacillus Strain

The safety of BS50 is the focus of the latest peer-reviewed publication from BIO-CAT Microbials. Posted in Microorganisms on May 17e2022, this manuscript lays the foundation for safety as BIO-CAT Microbials seeks GRAS status for the new Bacillus stump. The effectiveness of BS50 as a human probiotic will be explored at the upcoming Probiota Americas, June 1-3, 2022in washington d.c.

“We are proud to report the safety and efficacy of our new strain. It is the culmination of months of testing and development, and represents another example of the continued development of BCM strains.” says dr. Jessica SpearsPhD, R&D Director at BIO-CAT Microbials.

BIO-CAT Microbials continues to be an industry leader in microbial solutions. The company recently announced a new capital increase in Troy, Virginiaadding redundancy and significantly increasing capacity, which is currently underway with an expected completion date of 2023.

About BIO-CAT Microbes

BIO-CAT Microbials, LLC was founded in 2004 by BIO-CAT Inc., an enzyme industry leader located in Troy, Virginia. For 17 years, BIO-CAT Microbials, LLC has focused on three primary life science verticals: human, animal and plant nutrition. BIO-CAT Microbials, LLC continues to be an innovative, global biotechnology leader supporting its customers with advanced microbial solutions. As industry experts, their science-led team specializes in strain development, fermentation and product development. For more information, visit www.bio-cat.com or contact [email protected].

SOURCE BIO-CAT Microbials LLC

About Cody E. Vaughn

Check Also

Publication of a manuscript for the improvement of relations between cancer scientists and patient advocates

HOUSTON, June 30, 2022 /PRNewswire/ — Theresa’s Research Foundation is delighted to announce a new …